Paediatric compositions for treating1 multiple sclerosis

Details for Australian Patent Application No. 2009259950 (hide)

Owner Novartis AG

Inventors Bastien, Marie-Claude; Kovarik, John; Schmouder, Robert

Agent Davies Collison Cave

Pub. Number AU-A-2009259950

PCT Pub. Number WO2009/155475

Priority 61/132,621 20.06.08 US

Filing date 19 June 2009

Wipo publication date 23 December 2009

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/155475 Priority application(s): WO2009/155475

14 April 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Bastien, Marie-Claude; Kovarik, John; Schmouder, Robert; David, Olivier; Karlsson, Goeril and Bouillon, Thomas

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009259951-Compositions and methods of use of ORF 554 from beta hemolytic Strepto- coccal strains

2009259948-Information rights management